Cellectis (CLLS) Return on Sales Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 4.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -3.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 |
| Dec 31, 2025 | -6.00 |
| Sep 30, 2025 | 0.00 |
| Mar 31, 2025 | -3.00 |
| Dec 31, 2024 | -14.00 |
| Sep 30, 2024 | 0.00 |
| Mar 31, 2024 | 36.00 |
| Dec 31, 2023 | 11.00 |
| Sep 30, 2023 | 33.00 |
| Jun 30, 2023 | 74.00 |
| Mar 31, 2023 | -30.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | -28.00 |
| Jun 30, 2022 | 3.00 |
| Mar 31, 2022 | -2.00 |
| Dec 31, 2021 | 2.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 8.00 |
| Mar 31, 2021 | -2.00 |
| Dec 31, 2020 | 6.00 |
| Sep 30, 2020 | -2.00 |
| Jun 30, 2020 | 19.00 |
| Mar 31, 2020 | 23.00 |
| Dec 31, 2019 | 22.00 |
| Sep 30, 2019 | 29.00 |
| Jun 30, 2019 | -26.00 |
| Mar 31, 2019 | -18.00 |
| Dec 31, 2018 | -26.00 |
| Sep 30, 2018 | -28.00 |
| Jun 30, 2018 | -1.00 |
| Mar 31, 2018 | -1.00 |
| Dec 31, 2017 | -2.00 |
| Sep 30, 2017 | -3.00 |
| Jun 30, 2017 | 14.00 |
| Mar 31, 2017 | 0.00 |
| Dec 31, 2016 | -2.00 |
| Jun 30, 2016 | -15.00 |
| Mar 31, 2016 | -3.00 |